Trademark: BLUE EARTH 2326271
Word
BLUE EARTH
ID
2326271
Trademark Type
Word
Status
Protected: Registered/protected
Registration Date
02 December 2021
Renewal Date
02 December 2031
Owner(s)
Service
Goods and Services:
Class 1:
Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive elements for scientific purposes; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging (non-medical).
Chemicals for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracers; alpha- and beta-emitting radionuclides for use in radionuclide therapy; radioactive elements for scientific purposes; synthetic amino acids for use in PET imaging and radionuclide therapy; reagents for use in PET imaging and radionuclide therapy; diagnostic scanning agents for in-vivo use (non-medical); chemicals for use in molecular imaging (non-medical).
Class 5:
PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic and therapeutic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging (for medical use); chemicals for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy.
PET tracers for medical use; PET tracers prepared for ingestion or injection into humans and animals; diagnostic and therapeutic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in molecular imaging (for medical use); chemicals for pharmaceutical use; pharmaceutical drugs; pharmaceutical preparations; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products; radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy.
Class 42:
Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.
Scientific and medical research and product design in relation to Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in relation to disease diagnosis and treatment; scientific and medical research in relation to molecular imaging; development of molecular imaging products; development of non-medical molecular imaging services; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific consultancy in relation to the aforesaid services.
Class 44:
Medical services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services.
Medical services; Positron Emission Tomography (PET) medical imaging services; radionuclide therapy services; medical imaging services; medical services in the diagnosis and treatment of conditions in the body; providing medical consultancy in relation to the aforesaid services; development of medical molecular imaging services.